Kevin McCarthy spent forty seven years selling into medical practices, most recently at Henry Schein, where he sat on the company's first Medical Sales Advisory Board. He recently retired. In this conversation with Dr. Adam Sewell, he explains what he saw from inside thousands of exam rooms and why he believes the independent practice model is cracking.

Kevin spent years pushing Henry Schein to move into peptides, IV therapy, and med spa supply. Legal killed it every time. After a small number of widely reported IV therapy deaths, the company walked away from the category entirely, even though it already supplied far more dangerous infusions to hospitals, surgery centers, and oncology centers under the same licensing framework. Kevin argues the risk logic never made sense and that the retreat left an emerging market wide open.

He also talks about the 1980s, when new technology was genuinely new and a rep could walk in with something a physician had never seen. That instinct for the unfamiliar led him somewhere unexpected: a nurse asked him to source an irrigation suction machine for her husband's film work, and Kevin ended up outfitting medical sets for "Born on the Fourth of July" and a run of other productions until Texas tax law sent the work to Georgia.

Other ground covered:

• How to vet a supplier before you place a first order, including why Kevin insists on talking to the people who actually built the product rather than the marketing team
• Why he sees nurse practitioners, PAs, and CRNAs leaving hospital burnout as the real engine of cash pay adoption
• The physician in Forney who converted his entire practice from insurance to cash pay wellness inside a year
• Why Kevin tells nervous startups to launch with one thing, not everything
• Running an internal patient survey to find out what your own patients are already buying elsewhere

Hosted by Adam Sewell, MD, Premier Regenerative Health.